Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Recruiting2
Other1

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT06528301Phase 1Recruiting
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL)Lymphoma, B-CellLymphoma, Large B-Cell, Diffuse (DLBCL)+1 more
StudydirectorStart date: 2025-03-10
NCT07735533Phase 1/2Recruiting
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
Diffuse Large B Cell Lymphoma (DLBCL)Grade 3b Follicular LymphomaHigh Grade B Cell Lymphoma+4 more
Studydirector
NCT07735546Phase 1Not Yet Recruiting
A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma
Multiple Myeloma (MM)Multiple Myeloma in Relapse
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma, B-CellLeukemia, Lymphocytic, Chronic, B-Cell+2 more
Similarity Score13%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell+1 more
Similarity Score10%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Lymphoma, B-CellLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, Diffuse
Similarity Score8%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, B-CellMultiple Myeloma
Similarity Score8%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple MyelomaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score8%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-HodgkinMultiple Myeloma
Similarity Score8%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-CellLymphoma, B-Cell
Similarity Score8%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Similarity Score5%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple Myeloma
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06528301Phase 1StudyDirector

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL)Lymphoma, B-CellLymphoma, Large B-Cell, Diffuse (DLBCL)+1 more
Recruiting
NCT07735533Phase 1/2StudyDirector

A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies

Diffuse Large B Cell Lymphoma (DLBCL)Grade 3b Follicular LymphomaHigh Grade B Cell Lymphoma+4 more
Recruiting
NCT07735546Phase 1StudyDirector

A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma (MM)Multiple Myeloma in Relapse
Not Yet Recruiting

All 3 trials loaded